Search results
Charles Swanton is a clinician scientist and Deputy Clinical Director at the Crick Institute. He studies cancer evolution, genome instability and drug resistance, and leads the CRUK TRACERx clinical study.
- Oncotarget 1
Oncotarget 1 - Charles Swanton | Crick
- Annual Review of Cancer Biology 2
Explore a selection of reports that spotlight particular...
- Nature Reviews Urology 2
Nature Reviews Urology 2 - Charles Swanton | Crick
- Nature Aging 1
The Crick is an open door for curious minds. A place that...
- Tumour Biology 245
Tumour Biology 245 - Charles Swanton | Crick
- Nature Medicine 9
Nature Medicine 9 - Charles Swanton | Crick
- Cell Reports Medicine 1
Explore a selection of reports that spotlight particular...
- Nature Reviews Disease Primers 1
Nature Reviews Disease Primers 1 - Charles Swanton | Crick
- Oncotarget 1
Swanton is a senior group leader at London's Francis Crick Institute, [3] Royal Society Napier Professor in Cancer [4] and thoracic medical oncologist at University College London [5] and University College London Hospitals, [6] [7] co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of ...
Professor Swanton leads a team at the Francis Crick Institute that studies how lung cancers evolve and respond to treatment. He is also the Chief Clinician of Cancer Research UK, a charity that funds and supports cancer research and awareness.
- 2 Redman Place, E20 1JQ, London
Cancer Evolution and Genome Instability Laboratory. We are studying how cancers evolve in the body to spread and become resistant to therapy and finding new ways to treat them more effectively.
Professor Charles Swanton is a senior group leader at the Francis Crick Institute and a thoracic medical oncologist at University College London Hospitals. He specialises in oncology and cancer research, and leads the CRUK TRACERx study to decipher lung cancer evolution.
Charles Swanton is a professor of personalised cancer medicine and a consultant thoracic oncologist at the Francis Crick Institute and UCL Hospitals. He is a leading researcher in lung cancer evolution and drug resistance, and a member of the ESMO Translational Research & Personalised Medicine Working Group.
Charles SWANTON, Chair in Personalised Cancer Medicine, University College London and Senior Group Leader Cancer Research UK London Research Institute | Cited by 58,393 | of The Francis Crick...
